115 MDS-005 STUDY: EFFECT OF BASELINE ENDOGENOUS EPO ON RBC TRANSFUSION INDEPENDENCE (RBC-TI) IN LENALIDOMIDE-TREATED PATIENTS WITH LOW/INTERMEDIATE-1-RISK MDS WITHOUT DEL(5Q)
Santini, V., Li, J.S., Swern, A.S., Almeida, A., Giagounidis, A., Fu, T., Hoenekopp, A., Beach, C.L., Skikne, B., Fenaux, P.Volume:
39
Language:
english
Journal:
Leukemia Research
DOI:
10.1016/S0145-2126(15)30116-8
Date:
April, 2015
File:
PDF, 55 KB
english, 2015